Literature DB >> 11859002

Synthesis and vasorelaxant activity of new coumarin and furocoumarin derivatives.

Manuel Campos-Toimil1, Francisco Orallo, Lourdes Santana, Eugenio Uriarte.   

Abstract

We have synthesized a new series of coumarins and furocoumarins and evaluated their vasorelaxant activity in rat aorta rings pre-contracted with noradrenaline or by depolarisation with high KCl. The new furocoumarins relax smooth vascular muscle with a profile similar to that of khellin (a furochromone that directly relaxes smooth muscle) and at a greater potency, suggesting that these compounds have a potential interest for the development of new and more efficient vasodilator drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859002     DOI: 10.1016/s0960-894x(02)00015-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Imperatorin is responsible for the vasodilatation activity of Angelica Dahurica var. Formosana regulated by nitric oxide in an endothelium-dependent manner.

Authors:  Hong Nie; Lan-zhen Meng; Jiu-yao Zhou; Xiao-feng Fan; Yong Luo-; Guang-wen Zhang
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

2.  Tyrosinase inhibitor activity of coumarin-resveratrol hybrids.

Authors:  Antonella Fais; Marcella Corda; Benedetta Era; M Benedetta Fadda; Maria Joao Matos; Elias Quezada; Lourdes Santana; Carmen Picciau; Gianni Podda; Giovanna Delogu
Journal:  Molecules       Date:  2009-07-13       Impact factor: 4.411

Review 3.  An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents.

Authors:  Laila Rubab; Sumbal Afroz; Sajjad Ahmad; Saddam Hussain; Iram Nawaz; Ali Irfan; Fozia Batool; Katarzyna Kotwica-Mojzych; Mariusz Mojzych
Journal:  Molecules       Date:  2022-02-28       Impact factor: 4.411

Review 4.  Ammi Visnaga L., a Potential Medicinal Plant: A Review.

Authors:  Noha Khalil; Mokhtar Bishr; Samar Desouky; Osama Salama
Journal:  Molecules       Date:  2020-01-12       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.